Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1971-10-7
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0006-6648
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-9
|
pubmed:dateRevised |
2000-12-18
|
pubmed:meshHeading |
pubmed-meshheading:5561769-Chemistry, Pharmaceutical,
pubmed-meshheading:5561769-Chloramphenicol,
pubmed-meshheading:5561769-Dosage Forms,
pubmed-meshheading:5561769-Drug Stability,
pubmed-meshheading:5561769-Drug Tolerance,
pubmed-meshheading:5561769-Injections,
pubmed-meshheading:5561769-Solubility,
pubmed-meshheading:5561769-Tetracycline
|
pubmed:year |
1971
|
pubmed:articleTitle |
[Maximal dose of extemporaneous injectabile preparations].
|
pubmed:publicationType |
Journal Article
|